May 8 (Reuters) - The European drugs regulator said on
Thursday its safety committee has confirmed suicidal thoughts as
a side effect of Organon's anti hair-loss drug
finasteride, following an EU-wide review of available data.
(Reporting by Sneha S K; Editing by Shinjini Ganguli)